• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Omalizumab may facilitate drug desensitization in patients failing standard protocols.

作者信息

Gemici Karaaslan Hatice Betul, Karabag Yilmaz Esra, Gulmez Ruveyda, Canpolat Nur, Kiykim Ayca, Cokugras Haluk Cezmi

机构信息

Department of Pediatric Immunology and Allergy, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Department of Pediatric Nephrology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

出版信息

Pediatr Allergy Immunol. 2022 May;33(5):e13783. doi: 10.1111/pai.13783.

DOI:10.1111/pai.13783
PMID:35616895
Abstract
摘要

相似文献

1
Omalizumab may facilitate drug desensitization in patients failing standard protocols.奥马珠单抗可能有助于对标准方案治疗失败的患者进行药物脱敏。
Pediatr Allergy Immunol. 2022 May;33(5):e13783. doi: 10.1111/pai.13783.
2
Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions.奥马珠单抗在卡铂诱导的严重过敏反应患者快速药物脱敏中的作用：有待解决的问题
J Investig Allergol Clin Immunol. 2020;30(4):298-300. doi: 10.18176/jiaci.0499. Epub 2020 Feb 25.
3
Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab.完成奥沙利铂脱敏方案后发生意外过敏反应：奥马珠单抗辅助治疗成功
J Investig Allergol Clin Immunol. 2019 Feb;29(1):53-55. doi: 10.18176/jiaci.0326.
4
Anaphylaxis after Elosulfase A infusion: Omalizumab as coadjuvant for enzyme replacement therapy desensitization.艾洛硫酸酯酶A输注后发生过敏反应：奥马珠单抗作为酶替代疗法脱敏的辅助药物
Pediatr Allergy Immunol. 2019 Jun;30(4):491-494. doi: 10.1111/pai.13049. Epub 2019 Apr 29.
5
Progestogen hypersensitivity: successful use of progesterone desensitisation and omalizumab to facilitate in vitro fertilisation.孕激素超敏反应：使用孕激素脱敏和奥马珠单抗成功促进体外受精。
Intern Med J. 2024 Oct;54(10):1749-1752. doi: 10.1111/imj.16517. Epub 2024 Sep 17.
6
The use of omalizumab in allergen immunotherapy.奥马珠单抗在变应原免疫治疗中的应用。
Clin Exp Allergy. 2018 Mar;48(3):232-240. doi: 10.1111/cea.13084. Epub 2018 Jan 30.
7
Is the high risk of anaphylaxis to omalizumab a contraindication to this treatment?奥马珠单抗引发过敏反应的高风险是否是这种治疗方法的禁忌症？
Eur J Dermatol. 2019 Feb 1;29(1):101-102. doi: 10.1684/ejd.2018.3454.
8
Successful desensitization of a patient with Fabry disease with agalsidase beta (Fabrazyme) anaphylaxis after omalizumab pretreatment.在奥马珠单抗预处理后，对患有法布里病且出现β-半乳糖苷酶（法布赞）过敏反应的患者成功进行脱敏治疗。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):96-98. doi: 10.1016/j.anai.2020.08.026. Epub 2020 Aug 29.
9
Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to omalizumab：A case report.快速皮下脱敏治疗奥马珠单抗迟发性过敏反应：1 例报告。
J Clin Pharm Ther. 2019 Jun;44(3):486-488. doi: 10.1111/jcpt.12827. Epub 2019 Mar 11.
10
Delayed hypersensitivity reactions to multiple aromatase inhibitors followed by successful desensitization to letrozole.对多种芳香化酶抑制剂的迟发型超敏反应，随后成功脱敏至来曲唑。
Ann Allergy Asthma Immunol. 2021 Sep;127(3):378-379. doi: 10.1016/j.anai.2021.05.007. Epub 2021 May 15.

引用本文的文献

1
The Expanding Role of Omalizumab: From Food Allergy to Drug Desensitization.奥马珠单抗的作用拓展：从食物过敏到药物脱敏
Int J Mol Sci. 2025 Aug 14;26(16):7868. doi: 10.3390/ijms26167868.
2
Omalizumab pretreatment in a case of pediatric carboplatin desensitization.一例儿童卡铂脱敏治疗中的奥马珠单抗预处理。
Pediatr Allergy Immunol. 2025 Jun;36(6):e70136. doi: 10.1111/pai.70136.
3
Role of anti-IgE in immediate drug allergy.抗IgE在速发型药物过敏中的作用。
J Allergy Clin Immunol. 2025 Jan;155(1):84-86. doi: 10.1016/j.jaci.2024.09.021. Epub 2024 Oct 2.
4
Utilizing Biologics in Drug Desensitization.利用生物制剂进行药物脱敏。
Curr Allergy Asthma Rep. 2023 Jan;23(1):1-11. doi: 10.1007/s11882-022-01052-z. Epub 2022 Nov 29.
5
Therapeutical Targets in Allergic Inflammation.过敏性炎症的治疗靶点
Biomedicines. 2022 Nov 9;10(11):2874. doi: 10.3390/biomedicines10112874.